• Return to Headlines

United Therapeut Shares Up 27.1% Since SmarTrend's Buy Recommendation (UTHR)

By Shiri Gupta

SmarTrend identified an Uptrend for United Therapeut (NASDAQ:UTHR) on March 25th, 2020 at $90.09. In approximately 2 months, United Therapeut has returned 27.09% as of today's recent price of $114.49.

In the past 52 weeks, shares of United Therapeut have traded between a low of $74.31 and a high of $116.98 and are now at $115.75, which is 56% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.6% while the 200-day MA has risen 0.6%.

United Therapeutics Corporation develops pharmaceuticals to treat vascular diseases such as pulmonary hypertension and peripheral vascular disease. The Company's lead products are stable synthetic forms of prostacyclin and are delivered orally or subcutaneously.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of United Therapeut shares.

Log in and add United Therapeut (UTHR) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights united therapeut

Ticker(s): UTHR